CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.896
EU - Europa 1.738
AS - Asia 699
SA - Sud America 7
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.887
CN - Cina 636
GB - Regno Unito 456
IT - Italia 251
DE - Germania 223
SE - Svezia 223
IE - Irlanda 213
FR - Francia 189
RU - Federazione Russa 62
FI - Finlandia 56
UA - Ucraina 20
KR - Corea 12
VN - Vietnam 12
TR - Turchia 11
AT - Austria 9
CA - Canada 9
BE - Belgio 7
NL - Olanda 7
HK - Hong Kong 6
PT - Portogallo 6
IR - Iran 5
SG - Singapore 5
IN - India 4
AU - Australia 3
BR - Brasile 3
CH - Svizzera 3
LV - Lettonia 3
JP - Giappone 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KW - Kuwait 1
MA - Marocco 1
PE - Perù 1
PL - Polonia 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 4.350
Salva come PNG Salva come JPEG
Città #
Chandler 488
Southend 448
Dublin 208
Ashburn 167
Beijing 102
Jacksonville 100
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
Bologna 65
Ann Arbor 61
New York 59
Jinan 58
Shenyang 53
Nanjing 46
Sindelfingen 46
Helsinki 40
Verona 39
Woodbridge 35
Hebei 34
Seattle 33
Tianjin 28
Washington 27
Zhengzhou 26
Taiyuan 22
Changsha 21
Haikou 21
Hangzhou 20
Ningbo 19
Houston 17
Nanchang 17
Dongguan 16
Fairfield 15
Guangzhou 15
Jiaxing 15
Redwood City 15
San Francisco 12
Taizhou 12
Norwalk 11
Seoul 11
Venice 11
Falls Church 8
Fuzhou 8
Miami 8
Milan 8
Vienna 8
Brussels 7
Dearborn 7
Hong Kong 6
Lanzhou 6
Los Angeles 6
Boydton 5
Chicago 5
Dong Ket 5
Düsseldorf 5
Rome 5
Bari 4
Easton 4
Esslingen am Neckar 4
Falkenstein 4
Renton 4
Shanghai 4
Singapore 4
Toronto 4
Biandronno 3
Cerea 3
Detroit 3
Lappeenranta 3
Luino 3
Mehlingen 3
Nürnberg 3
São Paulo 3
Acquaviva Picena 2
Ardabil 2
Bergamo 2
Bratislava 2
Calais 2
Campobasso 2
Cascina 2
Chapel Hill 2
Chennai 2
Chiampo 2
Isola della Scala 2
Leawood 2
Lecce 2
Legnaro 2
London 2
Mesa 2
Minerbio 2
Muizenberg 2
Novokuznetsk 2
Offlaga 2
Ottawa 2
Pedrengo 2
Pompei 2
Riva 2
Saint Louis 2
San Mateo 2
Stockholm 2
Totale 2.956
Salva come PNG Salva come JPEG
Nome #
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 143
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 115
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 110
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 105
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 103
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 98
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 94
Anti-CCP antibodies and bone 94
Safety issues and adverse reactions with osteoporosis management 89
Could γ\δ T-cells explain zoledronic acid adverse events? 89
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 86
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 86
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 81
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 81
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 80
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 80
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 78
Rheumatoid arthritis, γδ T cells and bisphosphonates 76
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 73
The obesity paradox and osteoporosis 72
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 66
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 65
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 64
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 62
Association between environmental air pollution and rheumatoid arthritis flares 62
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 60
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 59
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 58
Correction to: The obesity paradox and osteoporosis 56
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 55
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 55
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 53
Osteoporosis in Rheumatic Diseases 53
Gender disparity in authorship of guidelines and recommendations in rheumatology 50
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 50
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 47
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 47
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 47
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 47
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 45
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 44
Calcium and vitamin D supplementation: when and why 44
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 43
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 43
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 42
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 42
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 42
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 40
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 40
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 40
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 40
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 39
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 39
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 38
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 38
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 38
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 38
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 37
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 36
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 36
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 33
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 31
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 31
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 31
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 30
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 29
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 28
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 26
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 24
Association between acute exposure to environmental air pollution and fragility hip fractures 23
Glucocorticoid-induced osteoporosis update 23
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 23
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 22
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 21
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis 21
Pragmatic Clinical Trials in Osteoporosis 21
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 21
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 19
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 19
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 18
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 18
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 17
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 15
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 14
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting 13
Balancing benefits and risks in the era of biologics 13
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 11
Regulation of bone mass in inflammatory diseases 11
Bone health status evaluation in men by means of REMS technology 11
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 11
Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic 10
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021 9
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 9
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 8
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on 'Diagnosis, risk stratification, and continuity of care of fragility fractures' based on a systematic literature review 7
Mining the pathogenesis of rheumatoid arthritis, the leading role of the environment 7
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 6
The line between COVID-19 pandemic and rare bone diseases 6
Response to Dr. Essouma regarding the article by Adami et al 6
Totale 4.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.546
article - articoli 18.546
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 2 2
2019/2020390 44 8 7 58 39 50 37 6 36 24 28 53
2020/2021656 96 132 22 114 58 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024777 40 70 89 125 80 202 54 44 30 43 0 0
Totale 4.550